# Ameriprise Financial Inc: financial statements, quarterly

AMP · NYSE · CIK 820027 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/amp.md) · [Financials](/companies/amp/financials.md) · [Filings](/companies/amp/filings.md) · [Insiders](/companies/amp/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/amp/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [4,076](/filings/0000820027-24-000094.md) | [3,992](/filings/0000820027-24-000015.md) | [4,325](/filings/0000820027-25-000048.md) | [4,392](/filings/0000820027-25-000066.md) | [4,560](/filings/0000820027-25-000080.md) | [4,649 d](/filings/0000820027-26-000016.md) | [4,481](/filings/0000820027-26-000027.md) | [4,490](/filings/0000820027-26-000043.md) | [4,893](/filings/0000820027-25-000080.md) | [5,047 d](/filings/0000820027-26-000016.md) | [4,886](/filings/0000820027-26-000027.md) | [5,013](/filings/0000820027-26-000043.md) |
| Income tax | $m | [245](/filings/0000820027-24-000094.md) | [117 d](/filings/0000820027-26-000016.md) | [229](/filings/0000820027-25-000048.md) | [222](/filings/0000820027-25-000066.md) | [134](/filings/0000820027-25-000080.md) | [281 d](/filings/0000820027-26-000016.md) | [104](/filings/0000820027-26-000027.md) | [291](/filings/0000820027-26-000043.md) | [262](/filings/0000820027-25-000080.md) | [284 d](/filings/0000820027-26-000016.md) | [229](/filings/0000820027-26-000027.md) | [329](/filings/0000820027-26-000043.md) |
| Net income | $m | [872](/filings/0000820027-24-000094.md) | [377](/filings/0000820027-24-000015.md) | [990](/filings/0000820027-25-000048.md) | [829](/filings/0000820027-25-000066.md) | [511](/filings/0000820027-25-000080.md) | [1,071 d](/filings/0000820027-26-000016.md) | [583](/filings/0000820027-26-000027.md) | [1,060](/filings/0000820027-26-000043.md) | [912](/filings/0000820027-25-000080.md) | [1,008 d](/filings/0000820027-26-000016.md) | [915](/filings/0000820027-26-000027.md) | [1,113](/filings/0000820027-26-000043.md) |
| Diluted EPS | $ per share | [8.14](/filings/0000820027-24-000094.md) | [3.57](/filings/0000820027-24-000015.md) | [9.46](/filings/0000820027-25-000048.md) | [8.02](/filings/0000820027-25-000066.md) | [5.00](/filings/0000820027-25-000080.md) | not reported | [5.83](/filings/0000820027-26-000027.md) | [10.73](/filings/0000820027-26-000043.md) | [9.33](/filings/0000820027-25-000080.md) | not reported | [9.68](/filings/0000820027-26-000027.md) | [11.98](/filings/0000820027-26-000043.md) |
| Basic EPS | $ per share | [8.31](/filings/0000820027-24-000094.md) | [3.64](/filings/0000820027-24-000015.md) | [9.63](/filings/0000820027-25-000048.md) | [8.16](/filings/0000820027-25-000066.md) | [5.09](/filings/0000820027-25-000080.md) | not reported | [5.92](/filings/0000820027-26-000027.md) | [10.88](/filings/0000820027-26-000043.md) | [9.47](/filings/0000820027-25-000080.md) | not reported | [9.81](/filings/0000820027-26-000027.md) | [12.12](/filings/0000820027-26-000043.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenuesNetOfInterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [165](/filings/0000820027-23-000105.md) | [175](/filings/0000820027-25-000013.md) | [180](/filings/0000820027-24-000055.md) | [180](/filings/0000820027-24-000079.md) | [186](/filings/0000820027-24-000094.md) | [181](/filings/0000820027-26-000016.md) | [179](/filings/0000820027-25-000048.md) | [185](/filings/0000820027-25-000066.md) | [190](/filings/0000820027-25-000080.md) | [191](/filings/0000820027-26-000043.md) | [184](/filings/0000820027-26-000027.md) | [198](/filings/0000820027-26-000043.md) |
| Total liabilities | $bn | [161](/filings/0000820027-23-000105.md) | [170](/filings/0000820027-25-000013.md) | [175](/filings/0000820027-24-000055.md) | [175](/filings/0000820027-24-000079.md) | [180](/filings/0000820027-24-000094.md) | [176](/filings/0000820027-26-000016.md) | [174](/filings/0000820027-25-000048.md) | [179](/filings/0000820027-25-000066.md) | [184](/filings/0000820027-25-000080.md) | [184](/filings/0000820027-26-000043.md) | [178](/filings/0000820027-26-000027.md) | [192](/filings/0000820027-26-000043.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [3.8](/filings/0000820027-24-000094.md) | [4.7](/filings/0000820027-26-000016.md) | [4.9](/filings/0000820027-25-000066.md) | [5.0](/filings/0000820027-25-000080.md) | [5.7](/filings/0000820027-25-000080.md) | [5.2](/filings/0000820027-26-000043.md) | [5.4](/filings/0000820027-26-000043.md) | [6.1](/filings/0000820027-26-000043.md) | [6.5](/filings/0000820027-25-000080.md) | [6.5](/filings/0000820027-26-000043.md) | [6.2](/filings/0000820027-26-000043.md) | [6.4](/filings/0000820027-26-000043.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [925 d](/filings/0000820027-24-000094.md) | [2,143 d](/filings/0000820027-26-000016.md) | [1,444](/filings/0000820027-25-000048.md) | [1,720 d](/filings/0000820027-25-000066.md) | [3,048 d](/filings/0000820027-25-000080.md) | [383 d](/filings/0000820027-26-000016.md) | [1,686](/filings/0000820027-26-000027.md) | [1,764 d](/filings/0000820027-26-000043.md) | [2,204 d](/filings/0000820027-25-000080.md) | [2,669 d](/filings/0000820027-26-000016.md) | [459](/filings/0000820027-26-000027.md) | [2,886 d](/filings/0000820027-26-000043.md) |
| Capital expenditure | $m | [50.0 d](/filings/0000820027-24-000094.md) | [50.0 d](/filings/0000820027-26-000016.md) | [52.0](/filings/0000820027-25-000048.md) | [17.0 d](/filings/0000820027-25-000066.md) | [49.0 d](/filings/0000820027-25-000080.md) | [58.0 d](/filings/0000820027-26-000016.md) | [36.0](/filings/0000820027-26-000027.md) | [38.0 d](/filings/0000820027-26-000043.md) | [44.0 d](/filings/0000820027-25-000080.md) | [44.0 d](/filings/0000820027-26-000016.md) | [29.0](/filings/0000820027-26-000027.md) | [37.0 d](/filings/0000820027-26-000043.md) |
| Dividends paid | $m | [139 d](/filings/0000820027-24-000094.md) | [136 d](/filings/0000820027-26-000016.md) | [138](/filings/0000820027-25-000048.md) | [147 d](/filings/0000820027-25-000066.md) | [145 d](/filings/0000820027-25-000080.md) | [144 d](/filings/0000820027-26-000016.md) | [144](/filings/0000820027-26-000027.md) | [152 d](/filings/0000820027-26-000043.md) | [151 d](/filings/0000820027-25-000080.md) | [149 d](/filings/0000820027-26-000016.md) | [148](/filings/0000820027-26-000027.md) | [152 d](/filings/0000820027-26-000043.md) |
| Share repurchases | $m | [545 d](/filings/0000820027-24-000094.md) | [467 d](/filings/0000820027-26-000016.md) | [628](/filings/0000820027-25-000048.md) | [573 d](/filings/0000820027-25-000066.md) | [582 d](/filings/0000820027-25-000080.md) | [665 d](/filings/0000820027-26-000016.md) | [730](/filings/0000820027-26-000027.md) | [581 d](/filings/0000820027-26-000043.md) | [701 d](/filings/0000820027-25-000080.md) | [895 d](/filings/0000820027-26-000016.md) | [874](/filings/0000820027-26-000027.md) | [779 d](/filings/0000820027-26-000043.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [110](/filings/0000820027-24-000055.md) | [108](/filings/0000820027-24-000079.md) | [107](/filings/0000820027-24-000094.md) | [106](/filings/0000820027-24-000015.md) | [105](/filings/0000820027-25-000048.md) | [103](/filings/0000820027-25-000066.md) | [102](/filings/0000820027-25-000080.md) | [100](/filings/0000820027-26-000027.md) | [98.8](/filings/0000820027-26-000043.md) | [97.8](/filings/0000820027-25-000080.md) | [94.5](/filings/0000820027-26-000027.md) | [92.9](/filings/0000820027-26-000043.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 88,333,219 at 2026-07-24, from the cover of the [10-Q filed 2026-08-04](/filings/0000820027-26-000043.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.